Privacy compliance obligations continue to evolve quickly, as lawmakers and regulators refine rules governing data collection ...

Hospitalization provides a crucial opportunity to support tobacco cessation. A QI initiative introduced a streamlined ...

Approval received in advance of FDA-assigned PDUFA date of June 5, 2026; Arvinas and Pfizer remain on track to announce selection of a third party – – VEPPANU offers a new therapeutic option in ...

The FDA has approved Saphnelo (anifrolumab-fnia) for subcutaneous administration in patients with systemic lupus ...

Alnylam Pharmaceuticals is well-positioned in the TTR amyloidosis market, with a robust franchise and reliable clinical asset ...

Once-weekly semaglutide was tied to a reduction in heavy drinking days among adults with obesity and alcohol use disorder, ...

In cystic fibrosis, ETI significantly reduced daily cough frequency and increased physical activity levels in patients aged 12 and older.

The CAGE questionnaire is a concise, four-question tool that helps nurses and clinicians screen for possible alcohol or drug misuse. Its straightforward design makes it practical for busy healthcare ...

Compared with placebo, semaglutide achieved larger reductions in heavy-drinking days (−41.1 vs −26.4 percentage points) and ...

It seems like everything can be done by phone these days. Credit cards, concert tickets and boarding passes have all migrated to the cloud. Now, driver’s ...

The California Department of Health has also revoked 280 hospice licenses over the last two years and is reviewing another ...

National competition, in collaboration with adMare BioInnovations, demonstrates AbbVie's commitment to a thriving biotech ecosystem in ...